| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $78.1M | +44.5% |
| Cost of Revenue | $38.7M | +23.3% |
| Gross Profit | $39.3M | +74.0% |
| R&D Expense | $9.8M | -5.3% |
| SG&A Expense | $34.0M | +24.2% |
| Operating Income | -$20.2M | +29.4% |
| Interest Expense | $1.6M | -48.9% |
| Pre-tax Income | -$12.5M | +62.1% |
| Income Tax | $54K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.2M | +22.3% |
| Accounts Receivable | $12.1M | -13.1% |
| Inventory | $10.5M | +62.1% |
| Current Assets | $46.1M | +15.4% |
| Total Assets | $49.5M | +12.2% |
| Current Liabilities | $36.4M | -19.2% |
| Long-term Debt | $4.3M | -27.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.2M | +52.4% |
| Capital Expenditures | $35K | +118.8% |
| Investing Cash Flow | -$761K | -1189.8% |
| Financing Cash Flow | $16.0M | -44.5% |
| Free Cash Flow | -$11.2M | +52.2% |
| +440.0% |
| Net Income | -$12.5M | +61.9% |
| EPS (Basic) | -$1.57 | +65.3% |
| EPS (Diluted) | -$1.57 | +65.3% |
| Total Liabilities |
| $66.3M |
| -10.1% |
| Stockholders' Equity | -$29.8M | +20.7% |